Cargando…

Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism

In this study, a diabetic kidney disease model was established by placing the test rats on a high-sugar/high-fat diet combined with streptozotocin induction. Histopathological examination (H&E, Masson, and PASM stain) showed pathological changes in the diabetic rat kidneys, in addition to fibrot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yan, Sun, Yanlei, Shao, Fengli, Zhang, Bo, Wang, Zhen, Li, Xinpeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635909/ https://www.ncbi.nlm.nih.gov/pubmed/34869779 http://dx.doi.org/10.1155/2021/7618166

Ejemplares similares

Low Molecular Weight Fucoidan Inhibits Pulmonary Fibrosis In Vivo and In Vitro via Antioxidant Activity
por: Dong, Huidan, et al.
Publicado: (2022)

Low Molecular Weight Fucoidan Prevents Radiation-Induced Fibrosis and Secondary Tumors in a Zebrafish Model
por: Wu, Szu-Yuan, et al.
Publicado: (2020)

Toxicological Evaluation of Low Molecular Weight Fucoidan in Vitro and in Vivo
por: Hwang, Pai-An, et al.
Publicado: (2016)

Preparation of Low-Molecular-Weight Fucoidan with Anticoagulant Activity by Photocatalytic Degradation Method
por: Qi, Yihui, et al.
Publicado: (2022)

Purification of a Low Molecular Weight Fucoidan for SPECT Molecular Imaging of Myocardial Infarction
por: Saboural, Pierre, et al.
Publicado: (2014)

Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis
por: Haddad, Oualid, et al.
Publicado: (2015)

Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer
por: Huang, Ching-Wen, et al.
Publicado: (2021)

Effects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes
por: Lin, Hong-Ting Victor, et al.
Publicado: (2017)

Anti-Photoaging Effects of Low Molecular-Weight Fucoidan on Ultraviolet B-Irradiated Mice
por: Kim, Young-In, et al.
Publicado: (2018)

Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis
por: Wang, Mei-Zi, et al.
Publicado: (2022)

Fucoidan Inhibition of Osteosarcoma Cells is Species and Molecular Weight Dependent
por: Gupta, Dhanak, et al.
Publicado: (2020)

Low Molecular Weight Fucoidan against Renal Ischemia–Reperfusion Injury via Inhibition of the MAPK Signaling Pathway
por: Chen, Jihui, et al.
Publicado: (2013)

Low molecular weight fucoidan protects renal tubular cells from injury induced by albumin overload
por: Jia, Yingli, et al.
Publicado: (2016)

Relationship between Oversulfation and Conformation of Low and High Molecular Weight Fucoidans and Evaluation of Their in Vitro Anticancer Activity
por: Cho, Myoung Lae, et al.
Publicado: (2010)

Low molecular weight fucoidan attenuates experimental abdominal aortic aneurysm through interfering the leukocyte-endothelial cells interaction
por: Zhou, Min, et al.
Publicado: (2018)

Fucoidan Extracted from the New Zealand Undaria pinnatifida—Physicochemical Comparison against Five Other Fucoidans: Unique Low Molecular Weight Fraction Bioactivity in Breast Cancer Cell Lines
por: Lu, Jun, et al.
Publicado: (2018)

Protective Effect of Low-Molecular-Weight Fucoidan on Radiation-Induced Fibrosis Through TGF-β1/Smad Pathway-Mediated Inhibition of Collagen I Accumulation
por: Wu, Szu-Yuan, et al.
Publicado: (2020)

Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis
por: Yu, Xinfeng, et al.
Publicado: (2014)

Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys
por: Peng, Hui, et al.
Publicado: (2017)

Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia
por: Chen, Meng-Chuan, et al.
Publicado: (2015)

Promoting Wound Healing Using Low Molecular Weight Fucoidan in a Full-Thickness Dermal Excision Rat Model
por: Park, Jun-Hyeong, et al.
Publicado: (2017)

In Vitro Anti-Orthohantavirus Activity of the High-and Low-Molecular-Weight Fractions of Fucoidan from the Brown Alga Fucus evanescens
por: Krylova, Natalia V., et al.
Publicado: (2021)

The Spectrum of Kidney Diseases in Children Associated with Low Molecular Weight Proteinuria
por: Salihu, Shpetim, et al.
Publicado: (2018)

Tailoring Kidney Transport of Organic Dyes with Low-Molecular-Weight PEGylation
por: Du, Bujie, et al.
Publicado: (2019)

Oral Single Dose Toxicity Study of Low Molecular Fucoidan in Mice
por: Jung, Young-Mi, et al.
Publicado: (2008)

Case Report: Low Rectal Cancer With Incidental Pelvic Solitary Kidney
por: Zhang, Xiang, et al.
Publicado: (2022)

Antibacterial and Antioxidant Capacities and Attenuation of Lipid Accumulation in 3T3-L1 Adipocytes by Low-Molecular-Weight Fucoidans Prepared from Compressional-Puffing-Pretreated Sargassum Crassifolium
por: Huang, Chun-Yung, et al.
Publicado: (2018)

Overview of the cellular and molecular basis of kidney fibrosis
por: Eddy, Allison A
Publicado: (2014)

In Vitro and In Vivo Dendritic Cell Immune Stimulation Effect of Low Molecular Weight Fucoidan from New Zealand Undaria pinnatifida
por: Liu, Litong, et al.
Publicado: (2022)

Fine-Dust-Induced Skin Inflammation: Low-Molecular-Weight Fucoidan Protects Keratinocytes and Underlying Fibroblasts in an Integrated Culture Model
por: Kirindage, Kirinde Gedara Isuru Sandanuwan, et al.
Publicado: (2022)

Fucoidan partly prevents CCl(4)-induced liver fibrosis
por: Hayashi, Shinji, et al.
Publicado: (2008)

Impact of Enzymatically Extracted High Molecular Weight Fucoidan on Lipopolysaccharide-Induced Endothelial Activation and Leukocyte Adhesion
por: Kirsten, Nora, et al.
Publicado: (2023)

Amelioration of Chilling Injury by Fucoidan in Cold-Stored Cucumber via Membrane Lipid Metabolism Regulation
por: Zhang, Yupei, et al.
Publicado: (2023)

Efficacy of Low-Molecular-Weight Fucoidan as a Supplemental Therapy in Metastatic Colorectal Cancer Patients: A Double-Blind Randomized Controlled Trial †
por: Tsai, Hsiang-Lin, et al.
Publicado: (2017)

Molecular Targets and Related Biologic Activities of Fucoidan: A Review
por: Lin, Zhen, et al.
Publicado: (2020)

Fucoidan: Structure and Bioactivity
por: Li, Bo, et al.
Publicado: (2008)

Transforming growth factor β3 deficiency promotes defective lipid metabolism and fibrosis in murine kidney
por: Escasany, Elia, et al.
Publicado: (2021)

Fucoidan from Marine Brown Algae Inhibits Lipid Accumulation
por: Park, Min-Kyoung, et al.
Publicado: (2011)

Antitumor effect and molecular mechanism of fucoidan in NSCLC
por: Chen, Xiaohan, et al.
Publicado: (2021)

Dietary Supplementation with Low-Molecular-Weight Fucoidan Enhances Innate and Adaptive Immune Responses and Protects against Mycoplasma pneumoniae Antigen Stimulation
por: Hwang, Pai-An, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q6ctjb3dgmm72lbr096d7k54jg